A Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SEL-302 in Pediatric Subjects With MMA
Clinical trial NCT05778877 · WITHDRAWN
Trial details
- NCT number
- NCT05778877
- Sponsor
- Selecta Biosciences, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-19
- Primary completion
- 2025-08-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.